KONG GARHENG received a stock award from XERIS BIOPHARMA HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/5/2024ACC: 0001867096-24-000104
Director
Since Oct 2021
+50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
43.8%
6/5/2024
114.14K→164.14K
Total
Net shares
+50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/5/2024 | A · Award | +50K | — | — | 43.8% | 114.14K | 164.14K |
| Total | +50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported